Marlow, N;
Morris, T;
Brocklehurst, P;
Carr, R;
Cowan, FM;
Patel, N;
Petrou, S;
... Dore, C; + view all
Marlow, N;
Morris, T;
Brocklehurst, P;
Carr, R;
Cowan, FM;
Patel, N;
Petrou, S;
Redshaw, ME;
Modi, N;
Dore, C;
- view fewer
(2013)
A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 years.
Archives of Disease in Childhood Fetal and Neonatal Edition
, 98
(1)
F46 - F53.
10.1136/fetalneonatal-2011-301470.
![[thumbnail of Arch Dis Child Fetal Neonatal Ed-2013-Marlow-F46-53.pdf]](https://discovery-pp.ucl.ac.uk/style/images/fileicons/application_pdf.png)  Preview |
PDF
Arch Dis Child Fetal Neonatal Ed-2013-Marlow-F46-53.pdf
Available under License : See the attached licence file.
Download (225kB)
|
Abstract
The authors performed a randomised trial in very preterm small-for-gestational age (SGA) babies to determine if prophylaxis with granulocyte-macrophage colony-stimulating factor (GM-CSF) improves outcomes (the PROGRAMS trial). Despite increased neutrophil counts following GM-CSF, the authors reported no significant difference in neonatal sepsis-free survival.
| Type: |
Article
|
| Title: |
A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 years |
| Location: |
England |
| Open access status: |
An open access version is available from UCL Discovery |
| DOI: |
10.1136/fetalneonatal-2011-301470 |
| Publisher version: |
http://dx.doi.org/10.1136/fetalneonatal-2011-30147... |
| Language: |
English |
| Additional information: |
© 2012 The Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License (CC BY-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode
PMCID: PMC3533400 |
| Keywords: |
Developmental Disabilities, Disabled Children, Disease-Free Survival, Female, Granulocyte-Macrophage Colony-Stimulating Factor, Humans, Infant, Extremely Premature, Infant, Newborn, Infant, Premature, Diseases, Infant, Small for Gestational Age, Male, Sepsis |
| UCL classification: |
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > Comprehensive CTU at UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Applied Health Research
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health > Neonatology |
| URI: |
https://discovery-pp.ucl.ac.uk/id/eprint/1346532 |
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
